Indication
Multisystem Inflammatory Syndrome in Children (MIS-C)
3 clinical trials
5 products
Product
Remestemcel-LClinical trial
Intermediate-size Expanded Access of Remestemcel-L, Human Mesenchymal Stromal Cells, for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)Status:
Product
HydrocortisoneProduct
DiphenhydramineClinical trial
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied DrugsStatus: Recruiting, Estimated PCD: 2024-05-01
Product
POP02Clinical trial
Contrast Enhanced Ultrasound (CEUS) Detection of Microvascular Perfusion Impairment in COVID-19 Pediatric PatientsStatus: Completed, Estimated PCD: 2021-09-17
Product
Sulfur hexafluoride